As cancer therapies evolve and survival improves, the kidney sits at the centre of an expanding web of clinical challenges. This session examines three critical intersections: kidney function as a metric in determining treatment eligibility and safety; anemia at the crossroads of CKD and cancer, where overlapping mechanisms complicate diagnosis and management; and the evolving understanding of pre-malignant conditions like monoclonal gammopathy of renal significance, where early recognition and a shift toward induction-and-maintenance treatment paradigms are key to preserving kidney health.
| Time | Session |
|---|---|
|
09:15
09:37
|
Beyond the formula - rethinking kidney function in cancer care
Jennifer Lees
Speaker
|
|
09:37
10:00
|
Anemia at the crossroads of CKD and cancer
Kenar Jhaveri
Speaker
|
|
10:00
10:22
|
Treating MGRS: Are We Shifting to an Induction and Maintenance Paradigm
|
|
10:22
10:45
|
Q&A
|